Benzinga | Apr 21, 2021 08:03AM EDT

Enzo Biochem Announces FDA Has Cleared Its AMPICOLLECT Sample Collection Kit

Enzo Biochem, Inc. (NYSE:ENZ) ("Enzo" or the "Company"), a leading biosciences and diagnostics company, today announced that the Food and Drug Administration ("FDA") has cleared its AMPICOLLECT(tm) Sample Collection kit (manufactured under GMP) for distribution under Emergency Use Authorization. The AMPICOLLECT(tm) Sample Collection kit is now available for sample collection for COVID-19 testing protocols in the United States.